Goldline Pharmaceutical IPO GMP, Dates, Price Band & Listing Details

Goldline Pharmaceutical IPO will open for subscription on May 12, 2026 and the public issue will close on May 14, 2026. The IPO is launched through the Book Build Issue route. The company plans to mobilize nearly ₹11.61 crores through this offering, entirely consisting of a fresh issue of ₹11.61 crores along with an offer for sale of up to [.] equity shares having a face value of ₹10 each.

The price band for the Goldline Pharmaceutical IPO has been fixed at ₹41 to ₹43 per equity share. The issue allocation is divided into 35% for retail investors, 50% for QIBs, and 15% for HNI investors. The shares are proposed to be listed on BSE SME on May 19, 2026, while the basis of allotment is likely to be finalized on May 15, 2026.

In terms of financial performance, the company recorded revenue of ₹28.06 crores in 2025 compared to ₹23.57 crores in 2024. Net profit increased to ₹2.83 crores in 2025 from ₹1.81 crores in 2024. Based on the company’s improving financial growth and profitability, investors may consider this IPO for long-term investment opportunities.

Goldline Pharmaceutical IPO Details

Goldline Pharmaceutical IPO Dates

The Goldline Pharmaceutical IPO date is May 12 and the close date is May 14. The Goldline Pharmaceutical IPO allotment will be finalized on May 15 and the IPO listing on May 19.

Company Overview

Goldline Pharmaceutical Ltd. is a rapidly growing pharmaceutical company headquartered in Nagpur, Maharashtra. Established on 28 February 2005 by Mr. Amol Mujumdar, the company has expanded its operations across multiple Indian states including Maharashtra, Chhattisgarh, Madhya Pradesh, Odisha, Tamil Nadu, Rajasthan, Jharkhand, Goa, and Bihar. The company focuses on delivering quality therapeutic products while maintaining strong customer relationships and market-driven business practices. Its expanding product portfolio and innovative formulations have helped build a strong presence in the pharmaceutical sector.

Goldline Pharmaceutical operates with a dedicated marketing, product management, and field force team focused on sustainable business growth. The company continuously updates its product range with advanced formulations and brand extensions to meet changing healthcare demands. With a strong emphasis on employee development, operational efficiency, and customer satisfaction, Goldline Pharmaceutical aims to strengthen its market position and continue its expansion across India.